Toxoplasmosis, caused by the protozoan parasite Toxoplasma gondii, is a zoonotic infectious disease that affects most warm-blooded animals and humans. Infection occurs through two main routes: oral (via contaminated food, water, or contact with the feces of infected animals, mainly domestic cats) and perinatal (from a pregnant woman to her fetus). In most cases, toxoplasmosis is asymptomatic and may be mild. However, in immunocompromised individuals, such as those with AIDS or organ transplant recipients, toxoplasmosis can cause serious complications, including encephalitis and other systemic lesions. Toxoplasmosis also poses a risk to pregnant women, as it can cause fetal infections and severe congenital anomalies.
History of the disease and interesting historical facts
Toxoplasmosis was first described in 1908 in a guinea pig blood sample collected in Tokyo, but its causative agent, Toxoplasma gondii, was not isolated until 1910. Over the years, research has uncovered not only the various routes of transmission, but also the mechanisms that allow the parasite to evade the host immune response. Interestingly, in the 1970s, toxoplasmosis came under intense scrutiny for its effects on the behavior of infected animals, particularly interactions between cats and rodents. Some studies have shown that rodents infected with Toxoplasma gondii lose their natural fear of cats, facilitating their capture and transmission of the parasite to subsequent hosts.
Epidemiology
Millions of cases of toxoplasmosis are reported worldwide each year, making it one of the most common infections. Statistics show that between 30% and 50% of the adult population in different regions of the world are seropositive for antibodies to Toxoplasma gondii. In some countries, such as France and Mexico, this number can reach 80%. Incidence rates also vary by age group and by region, due to cultural, economic, and health factors. The increase in toxoplasmosis cases among pregnant women is a reason for special monitoring in this population group, especially in developing countries.
Genetic predisposition to this disease
To date, genetic studies of toxoplasmosis have identified several key genes that may play a role in a person’s susceptibility to this disease. In particular, genes responsible for the synthesis of interferons, such as IFNG, have demonstrated a link with the level of protection against toxoplasmosis. Some IL genes may also affect the immune response. Studies show that polymorphisms in genes responsible for HLA typing may determine the severity of toxoplasmosis in different individuals. In addition, the work of other immunomodulators, such as TLR genes, has also attracted the attention of the scientific community.
Risk factors for the development of this disease
Risk factors for toxoplasmosis can be divided into several categories:
- Physical factors:
- Presence of pets, especially cats;
- Contact with unprocessed meat;
- Careless handling of feces;
- Chemical factors:
- General ecology and sanitary conditions in the region;
- Level of knowledge about food safety;
- Other factors:
- The state of the immune system (such as HIV infection);
- Pregnancy, especially in the first trimester;
Diagnosis of this disease
The diagnosis of toxoplasmosis is based on both clinical manifestations and laboratory findings. The main symptoms associated with the infection range from flu-like manifestations to more serious neurological disorders. Laboratory tests include serologic tests for IgG and IgM antibodies to Toxoplasma gondii, which help to determine both current and past infection. Radiologic tests such as ultrasound and CT may be used to detect organ involvement, such as the liver or brain. This is especially important in the context of differential diagnosis with other diseases such as lymphoma or other infectious processes. It is also important to differentiate toxoplasmosis from other infections that can cause similar symptoms, such as mononucleosis.
Treatment
Treatment of toxoplasmosis depends on the clinical form of the disease and the patient's condition. In most cases, immunocompetent individuals require only supportive therapy to relieve symptoms. However, in severe forms, such as toxoplasmosis in HIV-positive patients, specific pharmacological therapy is used. The main antiprotozoal agents are pyrimethamine and sulfadoxine, which are often used in combination. In some cases, surgical intervention is required, for example, when abscesses form in the brain. Other approaches include the use of high-dose folate to reduce the toxicity of the main drugs.
List of medications used to treat this disease
- Pyrimethamine;
- Sulfadoxine;
- Clobazam;
- Acyclovir (in case of superinfection);
- Toxoplasmosis vaccine (under research);
Disease monitoring
Monitoring of toxoplasmosis involves regular follow-up examinations to track the dynamics of the disease and the effectiveness of treatment. The prognosis of the disease varies depending on the immune status of the patient, and, if untreated, toxoplasmosis can lead to serious complications, including death. Possible complications include toxoplasmic encephalitis, urethritis, and other systemic infections. It is important that all patients diagnosed be monitored by a specialist to ensure adequate therapy and prevention of complications.
Age-related features of the disease
Toxoplasmosis can manifest itself differently depending on the age group. In newborns and infants, the infection can be threatening and cause severe congenital anomalies, taditamine, a severe form of the disease can develop, including cataracts, hydrocephalus and other neurological manifestations. In adults, mild symptoms or a complete absence of clinical manifestations are most often observed. In the elderly and those with weakened immunity, the disease can proceed more aggressively, with a high probability of complications.
Questions and Answers
- How can you get toxoplasmosis? Infection can occur through consumption of undercooked meat, contact with contaminated cat feces, or through vertical transmission from mother to fetus during pregnancy.
- Who is at risk for toxoplasmosis? Those at risk include people with weakened immune systems, such as HIV-positive patients, and pregnant women.
- What are the main symptoms of toxoplasmosis? The main symptoms include fever, swollen lymph nodes, headaches and muscle pain; immunocompetent people may not show any symptoms.
- How is toxoplasmosis diagnosed? Diagnosis includes serological tests, radiological examinations and clinical observations.
- What treatment is effective for toxoplasmosis? Treatment includes antiprotozoal drugs such as pyrimethamine and sulfadoxine, with possible adjustments depending on the patient's condition.
